training
48 results
1 - 48
ibritumomab
papaverine
ibutilide
tositumomab (I 131 tositumomab)
hematopoietic progenitor cells, human cord blood
coagulation factor IX (Recombinant), Fc fusion protein
carboprost
lutetium lu 177 dotatate
dextranomer/hyaluronate
remimazolam
fenfluramine
alemtuzumab
dofetilide
lipid emulsion, injectable
alfentanil
remifentanil
loxapine
ustekinumab
sugammadex
benralizumab
daclizumab
pexidartinib
mycophenolate mofetil
methyl aminolevulinate
secukinumab
Overview of Risk Evaluation and Mitigation Systems (REMS)
C1-esterase inhibitor, recombinant
azficel-T
chloral hydrate
afamelanotide
C1-esterase inhibitor
pegvaliase
satralizumab
cantharidin
caplacizumab
bimekizumab
lixisenatide
lonapegsomatropin
colfosceril palmitate
SUFentanil
insulin glargine/lixisenatide
dinoprostone
melphalan
Medication Errors: Improving Practices and Patient Safety
elranatamab
beractant
collagenase clostridium histolyticum
buprenorphine





